• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罗米司亭作为辅助治疗犬难治性巨核细胞减少性免疫性血小板减少症。

Romiplostim as Adjunctive Treatment of Refractory Amegakaryocytic Immune Thrombocytopenia in a Dog.

机构信息

Companion Animal Clinic, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Private Veterinary Practice, Thessaloniki, Greece.

出版信息

Top Companion Anim Med. 2021 Mar;42:100488. doi: 10.1016/j.tcam.2020.100488. Epub 2020 Oct 25.

DOI:10.1016/j.tcam.2020.100488
PMID:33115689
Abstract

A 9-year-old, intact male, mixed-breed dog was admitted with a 3-day history of severe thrombocytopenia and bleeding diathesis. Physical examination revealed mucosal and cutaneous petechiae and ecchymoses, melena, and gross hematuria. Clinicopathologic evaluation indicated severe thrombocytopenia, anemia, and panhypoproteinemia. Serology for common endemic vector-borne pathogens was negative and thoracic and abdominal imaging was unremarkable. Bone marrow aspiration cytology revealed aplasia of the megakaryocytic lineage, in the context of a mildly hypoplastic myeloid and a normal erythroid series. A diagnosis of presumptive primary amegakaryocytic immune thrombocytopenia (ITP) was established. Treatment with vincristine, prednisolone, and mycophenolate mofetil along with several whole blood transfusions failed to achieve clinical and clinicopathologic remission. As an adjunct treatment, romiplostim was administered at a cumulative dose of 15 μg/kg, subcutaneously, in 2 sessions, 1 week apart, and complete clinical and hematological remission was noted 8 days postinitiation of romiplostim. Thirty-eight months later, the dog remains clinically healthy with no evidence of hematological relapse. Romiplostim could be a promising adjunctive treatment option in dogs with refractory ITP.

摘要

一只 9 岁、未绝育的雄性混血犬,因严重血小板减少和出血倾向病史入院 3 天。体格检查发现黏膜和皮肤瘀点和瘀斑、血便和肉眼血尿。临床病理评估提示严重血小板减少、贫血和全蛋白血症。常见地方性虫媒病原体的血清学检测结果为阴性,且胸腹部影像学检查未见异常。骨髓抽吸细胞学检查显示巨核细胞系发育不良,伴有轻度骨髓增生不良和正常红细胞系列。诊断为疑似原发性巨核细胞免疫性血小板减少症(ITP)。采用长春新碱、泼尼松龙和霉酚酸酯联合治疗,并多次输注全血,但未能达到临床和临床病理缓解。作为辅助治疗,给予罗米司亭,按 15μg/kg 剂量,皮下分 2 次给药,间隔 1 周,在开始罗米司亭治疗 8 天后观察到完全临床和血液学缓解。38 个月后,该犬仍保持临床健康,无血液学复发迹象。罗米司亭可能是治疗难治性 ITP 的一种有前途的辅助治疗选择。

相似文献

1
Romiplostim as Adjunctive Treatment of Refractory Amegakaryocytic Immune Thrombocytopenia in a Dog.罗米司亭作为辅助治疗犬难治性巨核细胞减少性免疫性血小板减少症。
Top Companion Anim Med. 2021 Mar;42:100488. doi: 10.1016/j.tcam.2020.100488. Epub 2020 Oct 25.
2
Treatment of 5 dogs with immune-mediated thrombocytopenia using Romiplostim.使用罗米司亭对5只免疫性血小板减少症犬进行治疗。
BMC Vet Res. 2016 Jun 10;12:96. doi: 10.1186/s12917-016-0718-4.
3
Romiplostim for treatment of thrombocytopenia in dogs: A retrospective assessment and clinical outcomes.罗米司亭治疗犬血小板减少症:回顾性评估和临床结局。
J Vet Intern Med. 2024 Jul-Aug;38(4):2158-2164. doi: 10.1111/jvim.17131. Epub 2024 Jun 22.
4
Thrombopoietin receptor agonists in refractory immune thrombocytopenia: differential responses to eltrombopag and romiplostim: a case report and possible explanations.难治性免疫性血小板减少症中的血小板生成素受体激动剂:艾曲泊帕和罗米司亭的反应差异:一例病例报告及可能的解释。
J Clin Pharm Ther. 2012 Dec;37(6):729-32. doi: 10.1111/j.1365-2710.2012.01353.x. Epub 2012 May 14.
5
Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP Registry.在常规临床实践中用罗米司亭治疗原发免疫性血小板减少症(ITP):来自英国 ITP 注册研究的回顾性研究。
Eur J Haematol. 2019 May;102(5):416-423. doi: 10.1111/ejh.13221. Epub 2019 Mar 7.
6
[Successful switching from eltrombopag to romiplostim in a pediatric patient with refractory chronic ITP].[一名难治性慢性免疫性血小板减少症儿科患者从艾曲泊帕成功转换为罗米司亭]
Rinsho Ketsueki. 2015 May;56(5):511-3. doi: 10.11406/rinketsu.56.511.
7
Thrombopoietin Receptor Agonists: Eltrombopag and Romiplostim for the Treatment of Chronic Immune Thrombocytopenia Purpura.血小板生成素受体激动剂:艾曲泊帕和罗米司亭用于治疗慢性免疫性血小板减少性紫癜
Clin J Oncol Nurs. 2019 Apr 1;23(2):212-216. doi: 10.1188/19.CJON.212-216.
8
Use of Romiplostim during pregnancy as a rescue therapy in primary immune thrombocytopenia: Literature review and case description.妊娠期间使用罗米司亭作为原发性免疫性血小板减少症的抢救治疗:文献复习和病例描述。
Platelets. 2020;31(3):403-406. doi: 10.1080/09537104.2019.1615613. Epub 2019 May 22.
9
Romiplostim in chronic immune thrombocytopenic purpura.罗米司亭治疗慢性免疫性血小板减少症。
Clin Ther. 2009 Sep;31(9):1887-907. doi: 10.1016/j.clinthera.2009.09.013.
10
Romiplostim therapy in children with unresponsive chronic immune thrombocytopenia.罗米司亭治疗对慢性免疫性血小板减少症反应不佳的儿童。
Platelets. 2012;23(4):264-73. doi: 10.3109/09537104.2011.619601. Epub 2012 Apr 3.

引用本文的文献

1
Use of Immunosuppression, Romiplostim, and Splenectomy to Achieve Remission in a British Shorthair Cat With Primary Immune-Mediated Thrombocytopenia.使用免疫抑制、罗米司亭和脾切除术使一只患有原发性免疫性血小板减少症的英国短毛猫达到缓解。
J Vet Intern Med. 2025 Jul-Aug;39(4):e70149. doi: 10.1111/jvim.70149.
2
Romiplostim for treatment of thrombocytopenia in dogs: A retrospective assessment and clinical outcomes.罗米司亭治疗犬血小板减少症:回顾性评估和临床结局。
J Vet Intern Med. 2024 Jul-Aug;38(4):2158-2164. doi: 10.1111/jvim.17131. Epub 2024 Jun 22.
3
ACVIM consensus statement on the treatment of immune thrombocytopenia in dogs and cats.
ACVIM 关于犬猫免疫性血小板减少症治疗的共识声明。
J Vet Intern Med. 2024 Jul-Aug;38(4):1982-2007. doi: 10.1111/jvim.17079. Epub 2024 May 23.
4
ACVIM consensus statement on the diagnosis of immune thrombocytopenia in dogs and cats.ACVIM 关于犬猫免疫性血小板减少症诊断的共识声明。
J Vet Intern Med. 2024 Jul-Aug;38(4):1958-1981. doi: 10.1111/jvim.16996. Epub 2024 May 16.